Pharmalytics No 3 Q1 2025

Access the latest Pharmalytics report here*.

For Pharma.Aero members only. * To open the document, type in the password SmartData.

Pharmalytics #3ย covers the first quarter of 2025 and dives deep into the forces currently reshaping the pharmaceutical logistics and supply chain landscape.

In this issue:

๐ŸŒ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐“๐ซ๐š๐๐ž ๐š๐ง๐ ๐ญ๐ก๐ž ๐„๐ซ๐จ๐ฌ๐ข๐จ๐ง ๐จ๐Ÿ ๐๐ซ๐ž๐๐ข๐œ๐ญ๐š๐›๐ข๐ฅ๐ข๐ญ๐ฒ: ๐€ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐๐ž๐ซ๐ฌ๐ฉ๐ž๐œ๐ญ๐ข๐ฏ๐ž
In just a few weeks, U.S. trade policy swings have gone from sweeping tariffs to sector-specific threats to temporary reprieves, shaking industry confidence. We explore how this volatility is reshaping global pharmaceutical supply chains.

๐Ÿ”Ž ๐…๐ซ๐จ๐ฆ ๐€๐ง๐ญ๐ข๐›๐ข๐จ๐ญ๐ข๐œ๐ฌ ๐ญ๐จ ๐‡๐จ๐ซ๐ฆ๐จ๐ง๐ž๐ฌ: ๐€ ๐ƒ๐ž๐ž๐ฉ ๐ƒ๐ข๐ฏ๐ž ๐ข๐ง๐ญ๐จ ๐ญ๐ก๐ž ๐„๐”โ€™๐ฌ ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ˆ๐ง๐ ๐ซ๐ž๐๐ข๐ž๐ง๐ญ ๐ˆ๐ฆ๐ฉ๐จ๐ซ๐ญ๐ฌ
Recent shortages across Europe exposed the growing dependence on China for essential drug components. We break down where vulnerabilities lie and what it means for Europe’s pharmaceutical security.

๐Ÿพ ๐Œ๐š๐ฉ๐ฉ๐ข๐ง๐  ๐†๐ฅ๐จ๐›๐š๐ฅ ๐•๐ž๐ญ๐ž๐ซ๐ข๐ง๐š๐ซ๐ฒ ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐“๐ซ๐š๐๐ž: ๐Œ๐š๐ฃ๐จ๐ซ ๐„๐ฑ๐ฉ๐จ๐ซ๐ญ๐ž๐ซ๐ฌ, ๐ˆ๐ฆ๐ฉ๐จ๐ซ๐ญ๐ž๐ซ๐ฌ, ๐š๐ง๐ ๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐“๐ซ๐ž๐ง๐๐ฌ
With veterinary pharmaceuticals growing faster than human pharma, we track how vaccine trade routes are evolving โ€” and whoโ€™s leading the charge.

โ„๏ธ๐๐ซ๐ž๐š๐ค๐ข๐ง๐  ๐ญ๐ก๐ž ๐‚๐จ๐ฅ๐ ๐‚๐ก๐š๐ข๐ง: ๐‡๐จ๐ฐ ๐“๐ก๐ž๐ซ๐ฆ๐จ๐ฌ๐ญ๐š๐›๐ฅ๐ž ๐“๐ž๐œ๐ก๐ง๐จ๐ฅ๐จ๐ ๐ข๐ž๐ฌ ๐€๐ซ๐ž ๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐•๐š๐œ๐œ๐ข๐ง๐ž ๐’๐ญ๐š๐›๐ข๐ฅ๐ข๐ญ๐ฒ ๐š๐ง๐ ๐†๐ฅ๐จ๐›๐š๐ฅ ๐‹๐จ๐ ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ
Driven by post-pandemic disruptions and rising geopolitical instability, scientists are pioneering innovations that extend vaccine shelf life, boost product resilience, and reduce dependence on costly cold chain systems.

๐Ÿšš ๐๐ก๐š๐ซ๐ฆ๐š & ๐‹๐ข๐Ÿ๐ž ๐’๐œ๐ข๐ž๐ง๐œ๐ž๐ฌ ๐‹๐จ๐ ๐ข๐ฌ๐ญ๐ข๐œ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ๐ฌ Q1 2025: Regional mergers, bold integrator moves, and a strategic redirection of supply chains away from geopolitical risk zones.

As a reminder, all the Pharmalytics reports are available in the Member Areaย of our website. Learn how to registerย here.

Pharmalytics is prepared exclusively for Pharma.Aero members, and while we ask that you do not share it outside your organization, we encourage you to share it with colleagues within your company. Furthermore, you can invite anyone from your organization to register and log in to the Member Area of our website to access all confidential documents available to our members.

My cart
Your cart is empty.

Looks like you haven't made a choice yet.

My cart
Your cart is empty.

Looks like you haven't made a choice yet.